Improved Prediction of Treatment Response Using Microarrays and Existing Biological Knowledge
- 12 April 2006
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 7 (3) , 495-501
- https://doi.org/10.2217/14622416.7.3.495
Abstract
A desired application for microarrays in the clinic is to predict treatment response from an often diverse patient population. We present a method for analyzing microarray data that is predicated on biological pathway and function knowledge as opposed to a purely data-driven initial analysis. From an analysis perspective, this methodology takes advantage of information that is available across genes on a single array, as well as differences in those patterns across measurements. By using biological knowledge in the initial analysis, the accuracy and robustness of microarray profile classification is enhanced, especially when low numbers of samples are available. For clinical studies, particularly Phase I or I/II studies, this technique is exceptionally advantageous.Keywords
This publication has 23 references indexed in Scilit:
- Regularized ROC method for disease classification and biomarker selection with microarray dataBioinformatics, 2005
- Reliability and Reproducibility of Gene Expression Measurements Using Amplified RNA from Laser-Microdissected Primary Breast Tissue with Oligonucleotide ArraysThe Journal of Molecular Diagnostics, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerPublished by Elsevier ,2005
- Reproducibility of Oligonucleotide Microarray Transcriptome AnalysesJournal of Biological Chemistry, 2002
- Expression profiling predicts outcome in breast cancerBreast Cancer Research, 2002
- Microarray data quality analysis: lessons from the AFGC projectPlant Molecular Biology, 2002
- Methods of Microarray Data AnalysisPublished by Springer Nature ,2002
- Predicting the clinical status of human breast cancer by using gene expression profilesProceedings of the National Academy of Sciences, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Data‐Snooping, Technical Trading Rule Performance, and the BootstrapThe Journal of Finance, 1999